ReportsnReports

Generic and innovative drugs market in CIS countries 2012

 

Dallas, TX -- (ReleaseWire) -- 07/16/2012 -- Development forecasts for 2012-2014 Generic and innovative drugs in CIS countries 2012, Russia, Ukraine and Kazakhstan, Development forecasts for 2012-2014 provides complete coverage of current conditions in the three largest markets for these drugs and treatments among CIS countries. This report offers analysis of the complex legal environments in each country, with detailed accounts of the effects of recent and pending legislative activity on market development.

This all-inclusive document provides extensive coverage of pricing and reimbursement regulations for each of the covered countries, including VAT rates and mark-ups. It lists the top selling products and examines data exclusivity and expiration of patent periods along with the issues each country confronts when dealing with the prospects of counterfeit pharmaceuticals.

The report covers market leaders, supplying details on the largest producers in each country and for the overall CIS market. It examines regulatory changes that have affected the way companies conduct business and reviews the solutions they have chosen to adapt their business models to the ever changing marketplace. Also included – information on the views of physicians and patients on prescribing and using drugs from the generic and innovative categories.

Data describing the value of the generic and innovative drug markets in the covered countries from 2009-2014 is supplied, and current market size for these categories, along with projected size at the end of the period 2012-2014, is forecast, along with estimations of market share. Rates of growth for each of the three countries indicate which is expected to experience the fastest growth over the next two years.

Generic and innovative drugs in CIS countries 2012, Russia, Ukraine and Kazakhstan, Development forecasts for 2012-2014 also reports on the progress of efforts to comply with major strategic plans in each of the three countries that are set to affect market growth in significant ways beginning in 2012.

Buy your copy of this report @ http://www.reportsnreports.com/reports/175767-generic-and-innovative-drugs-market-in-cis-countries-2012-russia-ukraine-and-kazakhstan.html . Contact sales@reportsandreports.com for further information.

Table of Contents

I. Report methodology p.
II. Executive summary p.
III. Characteristics of generic and innovative drug markets in Russia, Ukraine and Kazakhstan p.
IV. Best-selling drugs in CIS countries p.
V. Drug patent expiry and data exclusivity periods in CIS p.
VI. Counterfeit medicines in CIS p.
VII. Reimbursement and pricing policies in Russia, Ukraine and Kazakhstan p.
VIII. Key manufacturers in CIS countries p.
IX. List of graphs p.
X. List of tables p.
XI. About PMR p.
XII. Contact PMR p.